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sented only 18% of total NSAIDs, its cost represented the 64%
of all NSAIDs. Glucosamine Sulfate represented the 60% of the
spending on SYSADOAs. Total pharmacological cost per patient
per year was 151,60€.
Conclusions: Knee osteoarthritis is a major cause of utilisation of
health care resources and sick leave. The total pharmacological
cost per patient per year was 151,60€. This amount is less than
needed to treat most chronic rheumatic diseases, and represents
a small fraction of the cost for the management of KOA.
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THE EFFECTS OF RUANGULI IN THE TREATMENT OF
EXPERIMENTAL OSTEOARTHRITIS OF THE KNEE IN
RABBITS
P. Jian, C. Yuelong, Z. Hongsheng, W. Xiang, S. Yinyu
Res. Inst. of Orthopaedics, Shanghai, China
Purpose: The objective of the present study was to investigate
the mRNA expression level of α-actin, MHC (myosin heavy chain)
isoforms (MHCI, IIa, IId/x, IIb), ADAMTS5 and Aggrecan in rabbit
osteoarthritis model. To explore the effects of Ruanguli (A kind
of Chinese herbal medicine compound recipe) in the treatment of
knee osteoarthritis.
Methods: 36 adult, female New Zealand white rabbits were ran-
domized in three groups, including sham control group, model
control group, treatment group (RuanGuLi 2mg/day, 4 weeks). Os-
teoarthritis of the knee was induced surgically in 28 rabbits (model
control group, treatment group). The other animals wee sham op-
erated. One week after operation, interfering measures were taken
into practice and lasted for 4 weeks. Animals were euthanized at
5 weeks postoperatively. RT-PCR was used to assess the mRNA
expression level of α-actin, MHC isoforms in quadriceps femoris,
Aggrecan and ADAMTS5 in knee cartilage. Mankin score was
used to assess cartilage degeneration in the knee.
Results: The result of Mankin score suggested that there was
signiﬁcant difference between model control group and treatment
group, Ruanguli treatment led to a signiﬁcant reduction in articular
cartilage degeneration. The results of RT-PCR suggested that the
expression level of MHCIIa mRNA,MHCIId/x mRNA and α-actin
mRNA in model group was signiﬁcantly lower than that in sham
control group. Ruanguli treatment signiﬁcantly increased the level
of MHCIIa,MHCIIb and α-actin mRNA when compared to model
control group. Ruanguli treatment led to a signiﬁcant increase in
the expression level of Aggrecan mRNA expression and reduction
in ADAMTS5 mRNA expression in articular cartilage.
Conclusions: In OA animals, the level of α-actin and MHC isforms
mRNA was lower compared with normal animals. Ruanguli sig-
niﬁcantly increased α-actin, some MHC and Aggrecan expression
as well as inhibited the expression of ADAMTS5 and reduced
cartilage degeneration in knee.
Acknowledgments: Funded by: The National Natural Science
Foundation of P.R. China (NO: 30300459) and Shanghai Leading
Academic Discipline Project (NO: T0303) and the Shanghai Youth
Phospherus Project (NO: 08QA14063)
536
EFFECT OF BOVINE CHONDROITIN SULFATE ON
IL-1BETA-STIMULATED HUMAN CHONDROCYTE C-20/A4
CELL LINE
F. Rousset1, L. Grange2,1, B. Lardy1, F. Heraud3, C. Trocme1,
E. Kurkdjian3, J. Gouze3, P. Gaudin1,2, R. Juvin2, F. Morel1
1GREPI TIMC Imag UMR CNRS 5525, UJF Enzymology
Laboratory Univ. Hosp. A. Michallon, Grenoble, France;
2Rheumatology Dept. Univ. Hosp. A. Michallon, Grenoble, France;
3Biotechonology Dept., Genevrier Laboratory, Sophia-Antipolis,
France
Purpose: The pathogenesis of primary osteoarthritis involves an
imbalance between anabolic and catabolic pathways by chondro-
cytes. Expression of pro-inﬂammatory cytokines and matrix metal-
loproteinases, chondrocyte hypertrophy and apoptosis participate
in the pathogenesis of osteoarthritis. Chondroitin sulfate (CS) is
an important structural component of cartilage and is approved as
a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in
Europe and other countries. Indeed, numerous studies showed the
good tolerance and its clinical beneﬁts to decrease pain, to improve
functional disability and to reduce non-steroidal anti-inﬂammatory
drug (NSAID) or acetaminophen consumption. However, mecha-
nisms of action in vivo and in vitro are unknown.The goal of the
study was to explore the effects of bovine CS on two main features
of osteoarthritis: proteolysis and chondrocyte apoptosis.
Methods: To address these questions, we submitted immortalized
human chondrocyte cell line C-20/A4 to bovine CS. Chondrocytes
were treated or not with 2 ng/ml human interleukin 1 beta (IL-
1 beta) alone or with 500 μg/ml of bovine CS for 20 hours in
DMEM culture medium free from foetal bovine serum. Expres-
sion of collagenases MMP-1, MMP-13 and their speciﬁc inhibitor
TIMP-1 was checked by ELISA assay in the culture medium.
ADAMTS-5 expression (a disintegrin and metalloproteinase with
thrombospondin motifs) was analyzed by western blot. Cell viabil-
ity was performed by trypan blue, cell cycle analysis and apoptosis
level were investigated by ﬂow cytometry.
Results: Treatment of chondrocytes by 500 μg/ml CS protected
the cells from death induced by 6 days incubation with 2 ng/mI
IL-1β: upon CS and IL-1, 75% cells were alive compare to 50%
without CS. Cell cycle analysis by FACS showed a signiﬁcant
decrease by CS of apoptosis in IL1-treated cells: 2% apoptotic
cells with versus 15% without). Moreover, CS decreased the IL-1
mediated expression of ADAMTS-5 contrary to that of MMP-1,
MMP-13 and TIMP-1.
Conclusions: The proinﬂammatory cytokine interleukin-1 beta
participates in the pathogenesis of cartilage damage in osteoarthri-
tis. In this study we provided experimental evidence that bovine
CS decreases ADAMTS-5 expression and protects from apop-
tosis of human chondrocyte cell line stimulated by IL-1β. These
results emphasize the potential beneﬁcial effect of bovine CS in
osteoarthritis.
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RECOVERY OF PHYSICAL FUNCTIONING AFTER TOTAL
HIP ARTHROPLASTY: A SYSTEMATIC REVIEW OF THE
LITERATURE
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Erasmus MC, Rotterdam, Netherlands
Purpose: Today’s total hip arthroplasty (THA) patients, who are
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likely to be younger and more active than ever, have high ex-
pectations regarding physical functioning after surgery. Physical
functioning has several aspects, such as perceived (problems in)
daily functioning, the capacity or ability to perform activities in a
(semi) laboratory setting, and actual performance in the home sit-
uation. To date, no comprehensive systematic review concerning
recovery of physical functioning after THA has been published. A
structured overview of recovery of physical functioning after THA
may help surgeons provide patients with better information before
surgery, as well as help patients and surgeons to form correspond-
ing expectations regarding functional outcome after THA.
The aim of this study is to summarize the state of knowledge
regarding the recovery of physical functioning after THA, and to
examine whether different aspects of functioning show the same
pattern of recovery.
Methods: The Medline and Embase medical literature databases
were searched up to October 2008. Two reviewers independently
assessed the inclusion criteria, the methodological quality and
extracted the results. Enough homogeneous data were available
to pool the data by means of meta-analysis for the results of
perceived physical functioning measures WOMAC Physical Func-
tioning (WOMAC PF) (score 0-68, 0 = best score) and SF-36
Physical Functioning (SF-36 PF) (score 0-100, 100 = best score),
and the capacity measure walking speed derived from gait analy-
sis. Data were pooled for the following time periods: preoperative,
one to three months postoperative, six to eight months postopera-
tive, and twelve months postoperative.
Results: Twenty-nine articles met the inclusion criteria. Perceived
physical functioning was measured with the WOMAC PF and the
SF-36 PF in ten studies, with the Oxford Hip score in three studies,
and with the AIMS Physical Activity subscale in one study. Twelve
months after surgery patients almost reached the maximal score
on the WOMAC PF (9.3±3.5). On the SF-36 PF hip patients
scored as good as a healthy study population in the Netherlands
(76.9±4.7 versus 77±17) twelve months after surgery. Measured
with the Oxford Hip Score most recovery had also taken place
within the ﬁrst twelve months after surgery.
The capacity of patients to perform activities in a laboratory setting
was measured with gait analysis in eleven studies, and with ca-
pacity tests in six studies. Actual functioning in the home situation
of the patients was assessed in one study. Twelve months after
surgery patients didn’t reach the norm scores of a reference pop-
ulation for walking speed (1.06±0.004 versus range age-matched
controls 0.91-1.63 m/s). Measured with capacity tests the recovery
of physical functioning increased in the ﬁrst twelve months after
surgery. We found no reference data of healthy controls for capac-
ity tests. Measured with an activity monitor in the home situation
of the patients six months after surgery the percentage movement
related activity of patients was lower than age-matched controls
(9.2% ± 3.7 versus 11.0% ± 2.9).
Conclusions: Perceived physical functioning seemed to reach
ceiling levels within twelve months after surgery. A different pattern
of recovery was seen for the capacity to perform activities in a
(semi) laboratory setting, and actual performance in the home
situation. Based on the results of this study patients can further
improve on capacity and actual performance after twelve months
after surgery. Only few studies had a follow up time of more than
twelve months, so little information is available about the recovery
of physical functioning longer than twelve months after surgery.
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CARDIAC AND THROMBOEMBOLIC MORBIDITY AFTER
TOTAL KNEE ARTHROPLASTY
J.A. Singh, M. Jensen, W. Harmsen, D. Lewallen, S. Gabriel
Mayo Clinic Sch. of Med., Rochester, MN
Purpose: Study the prevalence and predictors of cardiac and
thromboembolic events after primary Total Knee Arthroplasty
(TKA) in a population-based study using Rochester Epidemiol-
ogy Project and Total Joint Registry.
Methods: We studied the occurrence and predictors of cardiac
(myocardial infarction, arrhythmia and congestive heart failure)
and thromboembolic events (deep venous thrombosis, pulmonary
embolism) within 90-days of primary TKA in all Olmsted County
residents who underwent primary TKA at the Mayo Clinic, using
univariate and multivariable logistic regression analyses.
Results: There were 1551 TKA surgeries in Olmsted county res-
idents (37.4% men, 62.6% women). The prevalence of 90-days
post-operative cardiac events was 8.1% overall, higher in patients
with pre-existing cardiac event (19.7%) compared to those without
(1.7%). The prevalence of 90-day post-operative thromboembolic
events was 5.2% overall, higher in patients with prior thromboem-
bolic event (3.6%) compared to those without (2.5%).
In patients with pre-existing cardiac events, odds of 90-day cardiac
events were signiﬁcantly higher in older subjects, Odds ratios
(OR; 95% conﬁdence interval (CI)), 1.22 (1.08,1.38; p=0.001) per
5-year increase, higher Charlson index, 1.67 (1.17,2.39; p<0.001)
per 5-point increase and higher ASA class III-IV, 2.43 (1.53,3.87;
p=0.005) relative to class I-II. Multivariable analyses conﬁrmed
that age, ASA and Charlson index were signiﬁcant predictors.
Older age, 1.66 (1.23,2.22; p=0.01) was a signiﬁcant predictor
of 90-day cardiac events in those without prior history of cardiac
events in univariate analysis.
In univariate analyses in those with pre-existing thromboembolic
events, odds of 90-day thromboembolic events were signiﬁcantly
higher in men, 2.98 (1.25,7.12; p=0.01) and in those with higher
Charlson index 1.88 (1.001,3.52; p=0.0495). Only older age was
signiﬁcant in multivariable analysis.
Older age, 1.19 (1.03,1.38; p=0.02) and higher Charlson index
score, 2.05 (1.30,3.24; p=0.002) were signiﬁcant predictors of
90-day thromboembolic events in patients with prior history of
thromboembolic events in univariate analyses. Multivariable anal-
yses found that Charlson index, but not age, was a signiﬁcant
predictor of 90-day thromboembolic events.
Conclusions:Older age, higher comorbidity and male gender pre-
dicted higher risk of 90-day cardiac and thromboembolic events af-
ter TKA. Knowledge of these risk factors can help inform surgeons
and patients regarding their outcomes. Optimal pre-operative co-
morbidity management may decrease peri-operative morbidity in
patients undergoing TKA.
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PREVALENCE AND PREDICTORS OF 90-DAY CARDIAC
AND THROMBOEMBOLIC EVENTS AFTER ELECTIVE
TOTAL HIP ARTHROPLASTY
J.A. Singh, M. Jensen, W. Harmsen, D. Lewallen, S. Gabriel
Mayo Clinic Sch. of Med., Rochester, MN
Purpose: To study the prevalence and predictors of cardiac and
thromboembolic events and mortality after Elective Primary Total
Hip Arthroplasty (THA) in a population-based study.
Methods: Using the Rochester Epidemiology Project and Total
Joint Registry, we identiﬁed all Olmsted County residents who
underwent elective primary THA at the Mayo Clinic between 1994
and 2008. We identiﬁed the occurrence of cardiac and thromboem-
